This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2015-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kadapa, IN (2015)
- Hyderabad, IN (2019)
Company Filing History:
Years Active: 2015-2019
Title: Subba Reddy Peddi Reddy: Innovator in Pharmaceutical Sciences
Introduction
Subba Reddy Peddi Reddy is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel drug formulations. With a total of 2 patents to his name, he continues to push the boundaries of innovation in medicine.
Latest Patents
His latest patents include a co-crystal of carfilzomib with maleic acid and a process for the preparation of pure carfilzomib. This application relates to the co-crystal of carfilzomib with maleic acid, detailing the processes for its preparation and the production of amorphous carfilzomib. Another significant patent involves the amorphous form of Apixaban, which is useful in creating pharmaceutically acceptable dosage forms, along with the processes for their preparation.
Career Highlights
Subba Reddy is currently associated with Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its commitment to innovation and quality. His work at the company has allowed him to contribute to the development of important pharmaceutical products that can improve patient outcomes.
Collaborations
He has collaborated with talented coworkers such as Jithin Jose and Md Arshad Alam, enhancing the innovative capabilities of his team. Their combined expertise has led to advancements in drug formulation and delivery systems.
Conclusion
Subba Reddy Peddi Reddy exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight his commitment to improving healthcare solutions. His work continues to inspire future advancements in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
